Dyne Therapeutics (DYN) Change in Acquisitions & Divestments (2021 - 2026)

Dyne Therapeutics' Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $28.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 864.58% year-over-year to $28.6 million; the TTM figure through Mar 2026 stood at $43.5 million (up 221.65% YoY), while the FY2025 annual figure was $17.9 million, up 69.0% from the prior year.
• Change in Acquisitions & Divestments was $28.6 million for Q1 2026 at Dyne Therapeutics, up from $9.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $28.6 million in Q1 2026 to a low of $1000.0 in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $5.6 million across 5 years, with a median of $2.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments plunged 99.94% in 2025, then soared 864.58% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $395000.0 in 2022, then soared by 363.04% to $1.8 million in 2023, then jumped by 381.9% to $8.8 million in 2024, then increased by 6.44% to $9.4 million in 2025, then jumped by 205.35% to $28.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $28.6 million (Q1 2026), $9.4 million (Q4 2025), and $1000.0 (Q3 2025), per Business Quant data.